Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivipansel in adults with sickle cell disease
NCT00911495Phase 2Completed
- Sponsor
- GlycoMimetics
- Start
- May 2009
- Primary completion
- Jul 2010
- Modality
- Bivalent/Multivalent Binders, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rivipansel in sickle cell disease (SCD), sponsored by GlycoMimetics. Started May 2009; status: completed.
02
Drugs
rivipansel
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT00911495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911495.